Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNSS | AMGN | BMY | GILD | VRTX |
| Company | Sunesis Pharmaceutic | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.35 | 265.72 | 44.68 | 65.50 | 393.52 |
| High | 24.80 | 271.68 | 45.37 | 66.35 | 399.68 |
| Low | 16.35 | 265.72 | 44.34 | 64.63 | 393.49 |
| Last | 18.62 | 270.08 | 44.85 | 65.42 | 397.50 |
| Change | +3.64 | +0.70 | +0.15 | +0.15 | -0.20 |
| % Change | +24.30% | +0.26% | +0.34% | +0.23% | -0.05% |
| Volume | 20,069,086 | 1,274,813 | 13,951,107 | 9,832,342 | 413,792 |
| 20-Day Average Volume | 6,608,405 | 2,090,365 | 12,755,459 | 6,907,289 | 928,265 |
| Previous Close | 14.98 | 269.38 | 44.70 | 65.27 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.35 | 270.04 | 49.49 | 68.30 | 401.29 |
| 20-Day Raw Stochastic | 62.71% | 44.43% | 8.75% | 11.53% | 21.78% |
| 20-Day Relative Strength | 78.29% | 46.56% | 31.06% | 30.37% | 42.64% |
| Weighted Alpha | +200.53 | +10.03 | -33.69 | -23.16 | +14.84 |
| Today's Opinion | 88% Buy | 56% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 40% Buy | 40% Buy | 8% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +35.37% since 02/17/21 | +0.77% since 04/19/24 | -7.61% since 04/19/24 | -1.71% since 04/19/24 | +0.85% since 04/19/24 |
| Low | 3.53 on 02/22/21 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 |
| High | 7.09 on 02/24/21 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +75.58% since 01/22/21 | -3.82% since 03/26/24 | -13.98% since 03/26/24 | -9.38% since 03/26/24 | -4.98% since 03/26/24 |
| Low | 2.35 on 01/28/21 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 7.09 on 02/24/21 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +291.18% since 11/24/20 | -13.08% since 01/26/24 | -9.04% since 01/26/24 | -17.48% since 01/26/24 | -7.56% since 01/26/24 |
| Low | 1.33 on 11/25/20 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 7.09 on 02/24/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +92.27% since 08/24/20 | +0.48% since 10/26/23 | -14.66% since 10/26/23 | -16.41% since 10/26/23 | +10.06% since 10/26/23 |
| Low | 1.12 on 11/06/20 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
| High | 7.09 on 02/24/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,255 | 144,488,960 | 90,596,128 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 18,093 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 2,070,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -23,330,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 2.21 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 03/09/21 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 6.51 | 9.98 | 29.82 |